Rozerem

ramelteon

(ra-mel-tee-on) ,

Rozerem

(trade name)

Classification

Therapeutic: sedative hypnotics
Pharmacologic: melatonin receptor agonists
Pregnancy Category: C

Indications

Treatment of insomnia characterized by difficult sleep onset.

Action

Activates melatonin receptors, which promotes maintenance of circadian rhythm, a part of the sleep-wake cycle.

Therapeutic effects

Easier onset of sleep.

Pharmacokinetics

Absorption: Well absorbed (84%), but bioavailability is low (1.8%) due to extensive first pass liver metabolism. Absorption ↑ by a high fat meal.
Distribution: Widely distributed to body tissues.
Metabolism and Excretion: Extensively metabolized by the liver; mainly by CYP1A2 enzyme system. Metabolites are excreted mostly in urine (88%); 4% excreted in feces.
Half-life: 1–2.6 hr.

Time/action profile (blood levels)

ROUTEONSETPEAKDURATION
POrapid30–90 minunknown

Contraindications/Precautions

Contraindicated in: Hypersensitivity;History of angioedema with previous use;Severe hepatic impairment;Concurrent use of fluvoxamine; Lactation: Lactation; Pediatric: Safety not established.
Use Cautiously in: Depression or history of suicidal ideation;Moderate hepatic impairment;Concurrent use of CYP3A4 inhibitors, such as ketoconazole;Concurrent use of CYP2C9 inhibitors, such as fluconazole; Obstetric: Use only if maternal benefit outweighs fetal risk.

Adverse Reactions/Side Effects

Central nervous system

  • abnormal thinking
  • behavior changes
  • dizziness
  • fatigue
  • hallucinations
  • headache
  • insomnia (worsened)
  • sleep—driving

Gastrointestinal

  • nausea

Endocrinologic

  • ↑ prolactin levels
  • ↓ testosterone levels

Miscellaneous

  • angioedema (life-threatening)

Interactions

Drug-Drug interaction

Blood levels and effects are ↑ by fluvoxamine ; concurrent use is contraindicated.Levels and effects may be ↓ by rifampin.Concurrent use of CYP3A4 inhibitors, such as ketoconazole, may ↑ levels and effects; use cautiously.Concurrent use of CYP2C9 inhibitors, such as fluconazole, may ↑ levels and effects; use cautiously.Donepezil and doxepin may ↑ levels.↑ risk of excessive CNS depression with other CNS depressants including alcohol, benzodiazepines, opioids, and other sedative/hypnotics.

Route/Dosage

Oral (Adults) 8 mg within 30 min of going to bed.

Availability (generic available)

Tablets: 8 mg

Nursing implications

Nursing assessment

  • Assess sleep patterns before and periodically throughout therapy.

Potential Nursing Diagnoses

 (Indications)
Risk for injury (Side Effects)

Implementation

  • Do not confuse Rozerem (ramelteon) with Razadyne (galantamine).
  • Do not administer with or immediately after a high-fat meal.
    • Before administering, reduce external stimuli and provide comfort measures to increase effectiveness of medication.
  • Oral: Administer 30 min prior to going to bed.

Patient/Family Teaching

  • Instruct patient to take ramelteon as directed, within 30 min of going to bed and to confine activities to those necessary to prepare for bed. Instruct patient to read the Medication Guide before starting and with each Rx refill; changes may occur.
  • Causes drowsiness. Caution patient to avoid driving and other activities requiring alertness until response to medication is known.
  • Caution patient that complex sleep-related behaviors (sleep-driving, making phone calls, preparing and eating food, having sex, sleep walking) may occur while asleep. Inform patient to notify health care professional if sleep-related behaviors (may include sleep-driving—driving while not fully awake after ingestion of a sedative-hypnotic product, with no memory of the event) occur.
  • Advise patient to notify health care professional immediately if signs of anaphylaxis (swelling of the tongue or throat, trouble breathing, and nausea and vomiting) or angioedema (severe facial swelling) occur; may occur as early as the first time the product is taken.
  • Caution patient to avoid concurrent use of alcohol or other CNS depressants.
  • Advise female patients to notify health care professional if pregnancy is planned or suspected or if breast feeding.

Evaluation/Desired Outcomes

  • Relief of insomnia.

Rozerem

a trademark for ramelteon.
Mentioned in ?
References in periodicals archive ?
SALES OF LUNESTA, 2011-2013 ($ THOUSANDS, UNITS IN THOUSANDS) 260 SYNTHON BV 260 BRIEF HISTORY 260 TAKEDA PHARMACEUTICAL COMPANY LIMITED 261 BRIEF HISTORY 261 PRODUCT 261 Rozerem 261 REVENUE HISTORY 261 TABLE 57 TAKEDA'S REVENUES, 2009-2013 (JPY MILLIONS) 262 TEMPUR SEALY INTERNATIONAL INC.
New medications, including doxepin (Silenor) 3 to 6 mg, Lunesta in tapering doses 3-2-1 mg, Rozerem 8 mg, and Saphris (for anxiety stabilization and sleep effect), are quite useful in stabilizing individuals.
7 Unlike Lipitor, however, even as branded Ambien's market share fell dramatically, the market share fell moderately for Rozerem (to 0.
Takeda Pharmaceuticals misrepresents its sleep aid Rozerem (ramelteon) in sales materials aimed at physicians who treat substance abusers by claiming the product has "no likelihood of abuse and no detectable toxicity," the Food and Drug Administration's Division of Drug Marketing, Advertising, and Communications charges.
The latest compound to enter the marketplace is Rozerem, a melatonin agonist receptor.
Ambien and Lunesta are two of the biggest sellers, but Rozerem is coming up fast.
to cease a television advertisement for its Rozerem tablets for the treatment of insomnia.
X] A Different Kind of Sleeping Pill: Rozerem (generic name: ramelteon) is a new option for people who have trouble falling, but not staying, asleep.
We see revenues for both companies increasing dramatically over the next few years, even though indiplon will most likely be the fourth new entrant into the insomnia space after the launches of Sepracor's Lunesta, Takeda Pharmaceutical's Rozerem, and Sanofi-Aventis Group's Ambien CR in 2005.
the physician's quick solution was to offer her a free sample of a drug called Rozerem (ramelteon).
Ramelteon, to be marketed as Rozerem by Takeda Pharmaceuticals Inc.
1 Will Generic Eszopiclone Seriously Affect Rozerem Sales?